Sep 10 |
EASD 2024: Cardiovascular and inflammatory markers reduce after orforglipron treatment
|
Sep 10 |
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
|
Sep 10 |
Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes
|
Sep 10 |
Best Momentum Stocks to Buy for September 10th
|
Sep 10 |
MRK Stock Dips After SMMT's Cancer Drug Outshines Keytruda in Study
|
Sep 10 |
New Strong Buy Stocks for September 10th
|
Sep 10 |
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
|
Sep 10 |
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
|
Sep 9 |
Lilly appoints insider as finance chief amid rising investments to boost capacity
|
Sep 9 |
Is Eli Lilly and Company (LLY) a Good Big Company Stock to Buy Now?
|